Legal & General Group PLC Axcella Health Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$3.08 - $5.13 $4,746 - $7,905	-1,541 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.55 - $6.72 $1,219 - $1,800	-268 Reduced 14.81%	1,541 $7,000
Q3 2020 Nov 13, 2020	BUY	$4.12 - $5.91 $935 - $1,341	227 Added 14.35%	1,809 $8,000
Q2 2020 Aug 14, 2020	BUY	$2.94 - $7.7 $3,019 - $7,907	1,027 Added 185.05%	1,582 $9,000
Q1 2020 May 14, 2020	SELL	$2.25 - $5.24 $2,711 - $6,314	-1,205 Reduced 68.47%	555 $2,000
Q4 2019 Feb 13, 2020	BUY	$3.08 - $5.9 $5,420 - $10,384	1,760 New	1,760 $7,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.